Protagonist Therapeutics, Inc (PTGX) Total liabilities 2017–2025
Protagonist Therapeutics, Inc (PTGX) total liabilities at each fiscal year-end, per SEC filings.
$53.5MFY2025 · since FY2017: $43.1M → $53.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $53.5M | -23.0% |
| FY2024 | $69.4M | +226.4% |
| FY2023 | $21.3M | -34.2% |
| FY2022 | $32.3M | -32.2% |
| FY2021 | $47.7M | +6.3% |
| FY2020 | $44.9M | -40.1% |
| FY2019 | $75.0M | +178.0% |
| FY2018 | $27.0M | -37.5% |
| FY2017 | $43.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice